# Topical Calcipotriene Treatment for Breast Cancer Immunoprevention

> **NCT03596073** · PHASE1 · TERMINATED · sponsor: **Massachusetts General Hospital** · enrollment: 43 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Topical Calcipotriene Ointment
- **OTHER:** Topical Vaseline

## Key facts

- **NCT ID:** NCT03596073
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-11-07
- **Primary completion:** 2020-08-31
- **Final completion:** 2020-08-31
- **Target enrollment:** 43 (ACTUAL)
- **Why stopped:** Interim analysis did not show the required cytokine induction by topical calcipotriene to justify continuation of the trial
- **Last updated:** 2025-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03596073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03596073, "Topical Calcipotriene Treatment for Breast Cancer Immunoprevention". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT03596073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*